Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor

Lindsay A.M. Rein; Firas El Chaer; Junichiro Yuda; Kazuya Shimoda; Raajit Rampal; Joseph M. Scandura; Akiyoshi Takami; James McCloskey; Michiko Ichii; Shuichi Shirane; Alessandra Iurlo; Prithviraj Bose; Alessandro Lucchesi; Giulia Benevolo; Idoroenyi Amanam; Pankit Vachhani; Srinivas K Tantravahi; Marcello Rotta; Yasushi Onishi; Jean-Jacques Kiladjian; Ciro Rinaldi; Nikki Granacher; Terrence Bradley; Anand Ashwin Patel; Michael Loschi; Samah Alimam; Stanley Cheung; Vincent Ribrag; Sujan Kabir; Masataka Seki; Karen Ansaldo; Guia Guffanti; Jinny Lee; Steven L. Warner; Jason M. Foulks; Ruben Mesa

doi:10.1182/blood-2024-200999

Back

Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor

Journal article

Peer reviewed

Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor

Lindsay A.M. Rein, Firas El Chaer, Junichiro Yuda, Kazuya Shimoda, Raajit Rampal, Joseph M. Scandura, Akiyoshi Takami, James McCloskey, Michiko Ichii, Shuichi Shirane, …

Blood, Vol.144(Supplement 1), pp.3179-3179

2024-11-05

DOI: https://doi.org/10.1182/blood-2024-200999

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor
Creators: Lindsay A.M. Rein
Firas El Chaer - University of Virginia Health System
Junichiro Yuda - National Cancer Center Hospital East
Kazuya Shimoda - University of Miyazaki
Raajit Rampal - Memorial Sloan Kettering Cancer Center
Joseph M. Scandura - Cornell University
Akiyoshi Takami - Aichi Medical University
James McCloskey - Hackensack Meridian Health
Michiko Ichii - Soka University
Shuichi Shirane - Juntendo University
Alessandra Iurlo - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Prithviraj Bose - The University of Texas MD Anderson Cancer Center
Alessandro Lucchesi - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Giulia Benevolo - Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
Idoroenyi Amanam - City Of Hope National Medical Center
Pankit Vachhani - University of Alabama at Birmingham
Srinivas K Tantravahi - Huntsman Cancer Institute
Marcello Rotta - Colorado Blood Cancer Institute
Yasushi Onishi - Tohoku University Hospital
Jean-Jacques Kiladjian
Ciro Rinaldi - Pilgrim Hospital
Nikki Granacher - ZNA Middelheim Hospital
Terrence Bradley - University of Miami Health System
Anand Ashwin Patel - University of Chicago
Michael Loschi - Hôpital l'Archet
Samah Alimam - University College London Hospitals NHS Foundation Trust
Stanley Cheung
Vincent Ribrag - Institut Gustave Roussy
Sujan Kabir
Masataka Seki
Karen Ansaldo
Guia Guffanti
Jinny Lee
Steven L. Warner
Jason M. Foulks
Ruben Mesa - Levine Cancer Institute
Publication Details: Blood, Vol.144(Supplement 1), pp.3179-3179
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032518765302976